SIGALA, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 9.971
AS - Asia 4.927
EU - Europa 4.446
SA - Sud America 867
AF - Africa 84
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.314
Nazione #
US - Stati Uniti d'America 9.830
SG - Singapore 1.687
CN - Cina 1.625
UA - Ucraina 893
BR - Brasile 731
IT - Italia 708
HK - Hong Kong 623
DE - Germania 611
PL - Polonia 578
FI - Finlandia 386
VN - Vietnam 344
FR - Francia 309
GB - Regno Unito 258
RU - Federazione Russa 209
TR - Turchia 181
IE - Irlanda 161
IN - India 158
SE - Svezia 92
CA - Canada 78
BD - Bangladesh 59
BE - Belgio 54
JP - Giappone 52
AR - Argentina 48
ID - Indonesia 46
NL - Olanda 42
CZ - Repubblica Ceca 34
MX - Messico 34
ZA - Sudafrica 34
IQ - Iraq 27
EC - Ecuador 26
ES - Italia 24
PK - Pakistan 22
AT - Austria 16
CL - Cile 14
AU - Australia 13
VE - Venezuela 12
IR - Iran 11
MA - Marocco 11
UZ - Uzbekistan 11
KE - Kenya 10
LT - Lituania 10
PY - Paraguay 10
CO - Colombia 9
DK - Danimarca 9
EE - Estonia 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
CH - Svizzera 7
CR - Costa Rica 6
JM - Giamaica 6
MU - Mauritius 6
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
DZ - Algeria 5
IL - Israele 5
JO - Giordania 5
LB - Libano 5
OM - Oman 5
PT - Portogallo 5
UY - Uruguay 5
EU - Europa 4
GR - Grecia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AL - Albania 3
GY - Guiana 3
KR - Corea 3
LV - Lettonia 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
ZW - Zimbabwe 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
ET - Etiopia 1
Totale 20.303
Città #
Fairfield 1.045
Ashburn 835
Woodbridge 835
Singapore 746
Jacksonville 652
Hong Kong 618
Warsaw 574
Houston 528
Seattle 426
Cambridge 421
Ann Arbor 376
Dallas 375
Wilmington 356
Beijing 348
Chandler 339
Princeton 291
Los Angeles 261
Chicago 241
Nanjing 227
New York 218
Helsinki 206
Brescia 200
Dearborn 169
Dublin 160
Istanbul 147
Munich 109
Des Moines 108
Nanchang 108
Ho Chi Minh City 105
Salt Lake City 100
Buffalo 94
The Dalles 87
Moscow 86
Shenyang 69
Secaucus 67
Hanoi 65
Turku 64
Shanghai 62
São Paulo 62
Changsha 60
Jinan 57
Redondo Beach 55
San Diego 55
Brussels 53
Tampa 52
Tianjin 50
Elk Grove Village 49
Milan 49
Santa Clara 49
Dong Ket 48
Hebei 48
San Francisco 45
Pune 44
West Jordan 44
Lancaster 41
Toronto 39
London 38
Kunming 32
Boardman 31
Jakarta 31
Jiaxing 31
Sterling 31
Tokyo 31
Brooklyn 29
Ningbo 27
Rio de Janeiro 25
Rome 24
Brno 23
Zhengzhou 23
Verona 22
Taizhou 21
Johannesburg 20
Nuremberg 20
Phoenix 19
Stockholm 19
Boston 18
Dalmine 18
Hangzhou 18
Orem 18
Guangzhou 17
Haikou 17
Poplar 17
Atlanta 16
Haiphong 16
Montreal 16
Denver 15
Düsseldorf 15
Norwalk 15
Romola 15
Miami 14
Brasília 13
Chennai 13
Dulles 13
Kyiv 13
Belo Horizonte 12
Ashiya 11
Frankfurt am Main 11
Kocaeli 11
Lanzhou 11
Olomouc 11
Totale 13.479
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 765
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 361
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 361
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 282
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 278
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 256
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 228
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 225
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 225
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 207
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 203
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 198
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 198
Immunotherapy failure in adrenocortical cancer: where next? 195
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 194
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 193
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 191
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 186
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 184
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 182
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 179
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 179
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 178
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 178
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 178
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 174
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 172
Palbociclib inhibits proliferation of human adrenocortical tumor cells 171
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 171
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 170
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 167
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 162
A new pharmacological approach to the facilitation of acetylcholine transmission. 161
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 161
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 160
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 158
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 157
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 152
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 150
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 149
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 145
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 145
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 143
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 141
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 140
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 139
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 139
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 137
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 134
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 133
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 132
Dopamine receptors are present in rat and human esophagus 132
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 130
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 130
Nerve growth factor signaling in prostate health and disease. 128
Sex-related variations in serum nerve growth factor concentration in humans. 127
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 124
Different neurotransmitter systems are involved in the development of esophageal achalasia 123
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 123
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 121
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 121
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 121
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 121
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 120
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 120
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 119
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 119
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 119
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 119
Adrenocortical carcinoma 119
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 116
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 116
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 116
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 114
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 113
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 113
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 113
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 112
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 111
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 111
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 111
Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment 111
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 109
Differential gene expression of dopamine D-2 receptor subtypes in rat chromaffin cells and sympathetic neurons in culture. 107
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 104
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 102
D-1 and D-2 dopamine receptors in rat lower esophageal sphincter: a functional study 102
Identification of Dopamine receptors in rat and human esophagus 101
MUSCARINIC RECEPTOR MESSENGER RNAs ARE DIFFERENTIALLY EXPRESSED IN MALE AND FEMALE NORMAL HUMAN BLADDER 101
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 101
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 100
Phenotype changes of prolactinomas 99
ALPHA 1 ADRENERGIC RECEPTOR SUBTYPES IN MALE AND FEMALE HUMAN URINARY BLADDER: SEX AND REGIONAL COMPARISON 99
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 97
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos 95
Stimulation of muscarinic receptors induces cell proliferation of human detrusor muscle cell 95
role of acetylcholine as a growth factor: focus on human urinary bladder 95
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 94
D-1 and D-2 dopamine receptors in rat esophagus: biochemical and functional characterization 94
Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease. 93
Totale 15.448
Categoria #
all - tutte 93.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.486 0 0 0 0 0 250 107 259 310 219 224 117
2021/20221.260 120 185 38 68 15 58 63 76 61 154 112 310
2022/20231.075 190 62 48 81 83 260 6 90 134 14 39 68
2023/20241.412 72 39 126 101 82 256 49 67 284 73 34 229
2024/20254.152 56 47 32 529 341 246 295 109 491 248 942 816
2025/20264.004 550 864 757 917 608 308 0 0 0 0 0 0
Totale 20.650